Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Scientific (CORZ) Research & Development (2021 - 2024)

Core Scientific has reported Research & Development over the past 4 years, most recently at $5.0 million for Q4 2024.

  • Quarterly results put Research & Development at $5.0 million for Q4 2024, up 167.38% from a year ago — trailing twelve months through Dec 2024 was $11.8 million (up 64.67% YoY), and the annual figure for FY2024 was $11.8 million, up 64.67%.
  • Research & Development reached $5.0 million in Q4 2024 per CORZ's latest filing, up from $2.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $14.8 million in Q2 2022 and bottomed at $1.2 million in Q1 2021.
  • Median Research & Development over the past 4 years was $2.2 million (2023), compared with a mean of $3.4 million.
  • The largest annual shift saw Research & Development soared 928.04% in 2022 before it crashed 88.9% in 2023.
  • Over 4 years, Research & Development stood at $3.4 million in 2021, then fell by 22.83% to $2.7 million in 2022, then dropped by 29.39% to $1.9 million in 2023, then skyrocketed by 167.38% to $5.0 million in 2024.
  • Business Quant data shows Research & Development for CORZ at $5.0 million in Q4 2024, $2.8 million in Q3 2024, and $2.2 million in Q2 2024.